Ausgabe 2/2003
Inhalt (7 Artikel)
Discovery and development of anti-angiogenic peptides: A structural link
Ruud P.M. Dings, Irina Nesmelova, Arjan W. Griffioen, Kevin H. Mayo
Generation and use of a tailored gene array to investigate vascular biology
Amanda L. Evans, Andrew S. Sharkey, Samir A. Saidi, Cristin G. Print, Roberto D. Catalano, Stephen K. Smith, D. Stephen Charnock-Jones
αvβ3 and αvβ5 integrin antagonists inhibit angiogenesis in vitro
Riccardo E. Nisato, Jean-Christophe Tille, Alfred Jonczyk, Simon L. Goodman, Michael S. Pepper
Preliminary studies on the anti-angiogenic potential of pomegranate fractions in vitro and in vivo
Masakazu Toi, Hiroko Bando, Cheppail Ramachandran, Steven J. Melnick, Atsushi Imai, Rose S. Fife, Raymond Eric Carr, Tsutomu Oikawa, Ephraim Philip Lansky
Verotoxin sensitivity of ECV304 cells in vitro and in vivo in a xenograft tumour model: VT1 as a tumour neovascular marker
Hannah M. Heath-Engel, Clifford A. Lingwood
Inhibition of angiogenic initiation and disruption of newly established human vascular networks by juice from Morinda citrifolia (noni)
Conrad A. Hornick, Amy Myers, Halina Sadowska-Krowicka, Catherine T. Anthony, Eugene A. Woltering
Induction of focal angiogenesis through adenoviral vector mediated vascular endothelial cell growth factor gene transfer in the mature mouse brain
Guo-Yuan Yang, Bin Xu, Tomoki Hashimoto, Madeleine Huey, Thomas Chaly Jr., Rong Wen, William L. Young